Cancer Research Technology (CRT) to lease new chemistry facilities at the Babraham Research Campus

On November 29, 2012 Babraham Bioscience Technologies has reported that Cancer Research Technology Limited (CRT), the cancer-focused technology development and commercialisation arm of Cancer Research UK – the world’s largest cancer charity, has taken a lease in the new chemistry building currently under construction at the Babraham Research Campus (Press release, Cancer Research Technology, NOV 29, 2012, View Source [SID1234523266]). The building is due for completion in April 2013 and will house part of CRT’s Discovery Laboratories, its early-stage drug discovery operation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Babraham Research Campus has established itself as a hub of bioscience innovation at the heart of the Cambridge cluster and is already home to 36 innovative biomedical companies. This new research facility has been funded through the £44M capital development project awarded to the Biotechnology and Biological Sciences Research Council (BBSRC), which was announced by the Chancellor in 2011.

The building offers around 16,000 sq ft of lettable space, which will include 24 fume hoods, open plan bench space, offices and meeting rooms. CRT has taken a lease on half of the building, which will accommodate up to 30 of their researchers working in the area of cancer therapeutics (both bioscience and chemistry).

This is the second building financed through this capital project funding, the first being Babraham’s most recent Bioincubator Building, Moneta, which opened in April 2012. To date there are five Bioincubator Buildings at the campus, underscoring Babraham’s continuing commitment to nurturing early-stage enterprises and supporting biomedical innovation in the region. The Babraham Research Campus is strategically supported by the BBSRC.